Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Salloway

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences|April 1, 1997
Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric AssociationP F Malloy, J L Cummings, C E Coffey, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Aducanumab: Appropriate Use Recommendations UpdateJ Cummings, G D Rabinovici, A Atri, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Lecanemab: Appropriate Use RecommendationsJ Cummings, L Apostolova, G D Rabinovici, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric AssociationJ L Cummings, C E Coffey, J D Duffy, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
The Journal of Prevention of Alzheimer'S Disease|August 7, 2015
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task ForceB Vellas, R Bateman, K Blennow, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric AssociationC E Coffey, J L Cummings, J D Duffy, et al.
The Journal of Prevention of Alzheimer'S Disease|May 2, 2017
Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform NetworkJ Cummings, P Aisen, R Barton, et al.
The Journal of Prevention of Alzheimer'S Disease|April 19, 2025
Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task ForceD Angioni, L Middleton, R Bateman, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Neuropsychiatry and Clinical Neurosciences|April 1, 1997
Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric AssociationP F Malloy, J L Cummings, C E Coffey, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Aducanumab: Appropriate Use Recommendations UpdateJ Cummings, G D Rabinovici, A Atri, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force ReportR J Bateman, K Blennow, R Doody, et al.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Lecanemab: Appropriate Use RecommendationsJ Cummings, L Apostolova, G D Rabinovici, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 21, 1998
The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric AssociationJ L Cummings, C E Coffey, J D Duffy, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
The Journal of Prevention of Alzheimer'S Disease|August 7, 2015
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task ForceB Vellas, R Bateman, K Blennow, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric AssociationC E Coffey, J L Cummings, J D Duffy, et al.
The Journal of Prevention of Alzheimer'S Disease|May 2, 2017
Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform NetworkJ Cummings, P Aisen, R Barton, et al.
The Journal of Prevention of Alzheimer'S Disease|April 19, 2025
Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task ForceD Angioni, L Middleton, R Bateman, et al.
Pageof 5